OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration

Table 2

Differential distribution of clinicopathological parameters in high and low OSM expression groups.

Characteristics	Low expression of OSM	High expression of OSM	value
	265	265
Pathologic T stage, (%)			0.019
T1-2	183 (34.5%)	157 (29.6%)
T3-4	82 (15.5%)	108 (20.4%)
Pathologic N stage, (%)			0.151
N0	119 (46.7%)	120 (47.0%)
N1	5 (2.0%)	11 (4.3%)
Pathologic M stage, (%)			0.017
M0	218 (43.8%)	202 (40.6%)
M1	29 (5.8%)	49 (9.8%)
Pathologic stage, (%)			0.011
Stage I-II	175 (33.2%)	147 (27.9%)
Stage III-IV	88 (16.7%)	117 (22.2%)
Gender, (%)			0.203
Female	100 (18.9%)	86 (16.2%)
Male	165 (31.1%)	179 (33.8%)
Age, (%)			0.082
≤60	122 (23.0%)	142 (26.8%)
>60	143 (27.0%)	123 (23.2%)
Histologic grade, (%)			0.002
G1-2	137 (26.2%)	104 (19.9%)
G3-4	121 (23.2%)	160 (30.7%)